Post hoc analysis supports OM-85's effectiveness in reducing asthma exacerbations and medication use in patients.
This secondary post hoc analysis supports the therapeutic benefit of OM-85 in patients with T2-high asthma who have frequent exacerbations despite adherence to SoC asthma therapy.
No takes yet. Share an insight, caveat, or question.
Cristopoulou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: